Ophthalmic Solutions
Showing 2601 - 2625 of 2,869
Assessment of Motivity Trial in Nice (go-cart)
Unknown status
- Assessment of Motivity
- go-cart
-
Nice, FranceCentre Mémoire de Ressources et de Recherche
Oct 12, 2012
Concerns About Falling, Aged Trial in Maastricht (an in-home cognitive behavioral program)
Completed
- Concerns About Falling
- Aged
- an in-home cognitive behavioral program
-
Maastricht, NetherlandsMaastricht University
Jul 9, 2012
Allergic Conjunctivitis Trial in United States (R89674 0.025% ophthalmic solution)
Completed
- Allergic Conjunctivitis
- R89674 0.025% ophthalmic solution
-
Louisville, Kentucky
- +5 more
Sep 26, 2011
Dry Eye Disease Trial in United States (Azithromycin Ophthalmic Solution, 1%, Placebo)
Completed
- Dry Eye Disease
- Azithromycin Ophthalmic Solution, 1%
- Placebo
-
Artesia, California
- +8 more
Sep 20, 2011
Anti-biotic Resistance Trial in Minneapolis, Saskatoon (moxifloxacin 0.5% HCI ophthalmic solution, gatifloxacin ophthalmic
Completed
- Anti-biotic Resistance
- moxifloxacin 0.5% HCI ophthalmic solution
- gatifloxacin ophthalmic solution 0.3%
-
Minneapolis, Minnesota
- +1 more
Nov 16, 2011
Healthy Trial in Rennes (20% amylose bread, 10% amylose bread, Carbohydrates)
Completed
- Healthy
- 20% amylose bread
- +2 more
-
Rennes, Bretagne, FranceRennes University Hospital
May 15, 2012
Blepharitis Trial in United States (Azithromycin ophthalmic solution, 1%, Placebo)
Completed
- Blepharitis
- Azithromycin ophthalmic solution, 1%
- Placebo
-
Little Rock, Arkansas
- +32 more
Sep 20, 2011
Healthy Trial in Heidelberg (Povidone K25 eye drops (povidone))
Completed
- Healthy
- Povidone K25 eye drops (povidone)
-
Heidelberg, GermanyNovartis Investigational Site
Nov 16, 2011
Type 2 Diabetes Trial in Toronto (oat beta-glucan, Placebo)
Completed
- Type 2 Diabetes
- oat beta-glucan
- Placebo
-
Toronto, Ontario, CanadaGILabs
Jun 1, 2012
Seasonal Allergic Conjunctivitis Trial in Singapore (Loteprednol etabonate 0.2%, Olopatadine 0.1%)
Completed
- Seasonal Allergic Conjunctivitis
- Loteprednol etabonate 0.2%
- Olopatadine 0.1%
-
Singapore, SingaporeBausch & Lomb Singapore
Feb 17, 2012
Allergic Conjunctivitis Trial in Rochester (Loteprednol etabonate base (QD), Loteprednol etabonate base (BID), Loteprednol
Completed
- Allergic Conjunctivitis
- Loteprednol etabonate base (QD)
- +4 more
-
Rochester, New YorkBausch & Lomb
Feb 14, 2012
Anxiety, Pain Trial in Qazvin (Melatonin, Gabapentin, )
Completed
- Anxiety
- Pain
- Melatonin
- +2 more
-
Qazvin, Iran, Islamic Republic ofQazvin university of medical science
Oct 10, 2012
Allergic Rhinitis, Allergic Conjunctivitis Trial in Mississauga (Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops,
Completed
- Allergic Rhinitis
- Allergic Conjunctivitis
- Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops
- Placebo
-
Mississauga, Ontario, CanadaCetero Research
Nov 18, 2011
Conjunctivitis, Keratitis, Blepharitis Trial in Singapore (Loteprednol and tobramycin, Tobramycin and dexamethasone)
Completed
- Conjunctivitis
- +2 more
- Loteprednol and tobramycin
- Tobramycin and dexamethasone
-
Singapore, SingaporeBausch & Lomb Inc
Feb 27, 2012
Radiation Retinopathy, Choroidal Melanoma Trial in New York (Ranibizumab, ranibizumab)
Completed
- Radiation Retinopathy
- Choroidal Melanoma
-
New York, New YorkThe New York Eye Cancer Center
Apr 25, 2012
Human Umbilical Vein Endothelial Cells (HUVEC)-Perfusion
Unknown status
- Thrombosis
- +2 more
-
Vienna, AustriaMedical University Vienna- Dept. of Clinical Pharmacology
Apr 22, 2012
Violence, Juvenile Delinquency, Social Problems Trial in Ann Arbor (Youth Empowerment Solutions for Peaceful Communities)
Completed
- Violence
- +3 more
- Youth Empowerment Solutions for Peaceful Communities
-
Ann Arbor, MichiganUniversity of Michigan School of Public Health
Apr 4, 2012
Bacterial Conjunctivitis Trial in Rochester (Besifloxacin, Vehicle (Placebo))
Completed
- Bacterial Conjunctivitis
- Besifloxacin
- Vehicle (Placebo)
-
Rochester, New YorkBausch & Lomb Incorporated
Feb 14, 2012
Allergic Conjunctivitis Trial (Olopatadine 0.1%, Tranilast 0.5%, Placebo (Olopatadine))
Completed
- Allergic Conjunctivitis
- Olopatadine 0.1%
- +3 more
- (no location specified)
May 29, 2012
Hypotrichosis Trial in Philadelphia (bimatoprost ophthalmic 0.03% solution, vehicle sterile solution ())
Completed
- Hypotrichosis
- bimatoprost ophthalmic 0.03% solution
- vehicle sterile solution (placebo)
-
Philadelphia, Pennsylvania(unnamed)
Nov 30, 2011
Coronary Artery Stenosis Trial in Saint-etienne (St Thomas, Custodiol)
Completed
- Coronary Artery Stenosis
- St Thomas
- Custodiol
-
Saint-etienne, FranceCHU de Saint-Eienne
Mar 16, 2012
Myocardial Injury Trial in Ankara (HTK solution, crystalloid cardioplegia solution)
Unknown status
- Myocardial Injury
- HTK solution
- crystalloid cardioplegia solution
-
Ankara, Çankaya, TurkeyBaskent University, Faculty of Medicine
Mar 6, 2012
Eye Diseases Trial in Fort Worth (Next Generation Ophthalmic Irrigating Solution (NGOIS), BSS Plus)
Completed
- Eye Diseases
- Next Generation Ophthalmic Irrigating Solution (NGOIS)
- BSS Plus
-
Fort Worth, TexasUnited States
Mar 1, 2012